Research
With World-Class R & D facility, we are committed to provide branded generics at an affordable cost. Our team of scientists are constantly putting their efforts and know-how to develop robust and cost-effective formulations.
Various dosage form developed by our R&D Team are
|
|
On-going Development
- Effervescent Tablets
- Tablet in Capsule
- Multi Release Tablet
Research
With World-Class R & D facility, we are committed to provide branded generics at affordable cost. Our team of scientists are constantly putting their efforts and know-how to develop robust and cost-effective formulations.
Various dosage form developed by our R&D Team are
|
|
On-going Development
- Effervescent Tablets
- Tablet in Capsule
- Multi Release Tablet
Our Global Reach
Latest News
Blood Donation Camp
Jun-2022
Woman's Day
Mar - 2021
As per WHO, it is important for all women to be vaccinated with Rubella Vaccines. On the occasion of women’s day, we have organized Rubella Vaccination program for all our female team members.
UDAAN
Jan - 2021
Under the UDAAN initiative, from last three years, we have organized many cultural activities for BioMatrixians with their families. This gives us opportunity to strengthen team bonding.
EFDA, Ethiopia
July - 2022
Our state-of-the-art manufacturing facility has been approved by EFDA, Ethiopia for Oral solid, Liquid and dry powder dosage formulations.
NDA,Uganda
Aug - 2022
It is an indeed proud moment for Biomatrix to achieve another successive approval for Oral solid, dry powder and liquid dosage formulation. With this continuous accreditation, we strive to develop world-class products and make them available worldwide.
Three Star Export House
OCT - 2023
This is a proud moment for us that we have been accorded the status of THREE STAR EXPORT HOUSE by the Directorate General of Foreign Trade in honour of our extraordinary export performance and significant contributions to the country's economy. We are incredibly proud of "Team BioMatrix" for achieving this significant milestone.